首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1615994

醫療三錄儀市場機會、成長促進因素、產業趨勢分析與預測 2024 - 2032

Medical Tricorder Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年09月03日 | 出版商:

Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球醫用三錄儀市場估值為37 億美元，預計2024 年至2032 年複合年成長率為6.1%。。糖尿病、心血管問題和呼吸系統疾病等慢性疾病的激增正在推動醫療三錄儀市場的發展。影響因素包括人口老化、久坐的生活方式、不健康的飲食和不斷上升的肥胖率。醫用三錄儀具有非侵入性監測功能，減少了去醫院的頻率。

整個醫用三錄儀產業根據技術、應用、配銷通路、最終用途和地區進行分類。依技術細分，醫用三錄儀市場分為感測器、生物感測器和成像技術。感測器和生物感測器領域的價值到 2023 年將達到 24 億美元，佔據重要的市場佔有率。感測器和生物感測器擅長測量大量的生理指標，包括心率、血壓、體溫和血糖水平。

這種廣泛的適用性意味著配備這些感測器的醫療三錄儀可以滿足從常規檢查到慢性病監督的各種健康監測需求。從應用角度來看，醫用三錄儀市場分為監測與診斷。監測領域將處於領先地位，預計到2032 年收入將達到約46 億美元。大。醫療三錄儀具有監測功能，可提供有關生命徵象和健康指標的即時見解，有助於有效管理這些狀況。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	37億美元
預測值	63 億美元
複合年成長率	6.1%

此外，醫用三錄儀的監控功能可增強預防性醫療保健。透過促進及早發現潛在的健康問題並識別健康指標的微妙變化，及時採取干涉措施成為可能。這不僅可以提高患者的治療效果，還可以減少醫療費用，從而推動該領域的成長。 2023 年，北美醫用三錄儀市場估值為 17 億美元，預計分析期間複合年成長率為 5%。

北美嚴格的法規，例如《藥品供應鏈安全法》(DSCSA)，對於推廣包括醫療三錄儀在內的先進診斷工具至關重要。此類法規強調需要對藥品進行細緻的追蹤和監控，從而促進採用複雜的設備來滿足法規遵循。此外，北美強大且技術先進的醫療保健基礎設施，加上其對創新的承諾，為醫療三錄儀等最先進解決方案的無縫整合鋪平了道路。

產業生態系統分析
產業影響力
- 成長動力
  - 慢性病盛行率增加
  - 感測器技術的技術進步
  - 日益重視預防保健
- 產業陷阱與挑戰
  - 設備成本高，加上資料隱私問題
成長潛力分析
監管環境
技術景觀
波特的分析
PESTEL分析
未來市場趨勢
差距分析

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按技術分類，2021 - 2032 年

主要趨勢
感測器和生物感測器
影像技術

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
監控
診斷

第 7 章：市場估計與預測：按配銷通路，2021 - 2032 年

主要趨勢
傳統實體店
電子商務

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院和診所
居家護理
其他最終用戶

第 9 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

AliveCor, Inc.
Avidhrt Inc
Basil Leaf Technologies, LLC
Biosense Technologies Private Limited
Butterfly Network, Inc.
Cardiomo Inc
ChroniSense Medical, Ltd.
Medtronic plc
MEDWAND SOLUTIONS, INC.
TytoCare Ltd
VitalConnect

簡介目錄

Product Code: 11230

The Global Medical Tricorder Market was valued at USD 3.7 billion in 2023 and is projected to grow at a CAGR of 6.1% from 2024 to 2032. The market's expansion is fueled by the rising prevalence of chronic diseases, advancements in sensor technologies, and an increasing focus on preventive care. The surge in chronic diseases like diabetes, cardiovascular issues, and respiratory disorders is propelling the medical tricorder market. Contributing factors include an aging population, sedentary lifestyles, unhealthy diets, and escalating obesity rates. Medical tricorders, with their non-invasive monitoring capabilities, lessen the frequency of hospital visits.

The overall medical tricorder industry is classified based on technology, application, distribution channel, end-use, and region. Segmented by technology, the medical tricorder market is divided into sensors biosensors, and imaging technology. The sensors and biosensors segment, valued at USD 2.4 billion in 2023, commanded a significant market share. Sensors and biosensors are adept at gauging a plethora of physiological metrics, including heart rate, blood pressure, body temperature, and glucose levels.

This broad applicability means medical tricorders, when outfitted with these sensors, can cater to diverse health monitoring needs, spanning from routine check-ups to chronic disease oversight. Application-wise, the medical tricorder market is divided into monitoring and diagnosis. The monitoring segment is set to lead, projecting revenues of approximately USD 4.6 billion by 2032. As chronic diseases like diabetes, hypertension, and cardiovascular issues become more prevalent, the demand for consistent and prolonged health monitoring intensifies. Medical tricorders, with their monitoring features, furnish real-time insights on vital signs and health metrics, aiding in the effective management of these conditions.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$3.7 Billion
Forecast Value	$6.3 Billion
CAGR	6.1%

Furthermore, the monitoring capabilities of medical tricorders bolster preventive healthcare. By facilitating early detection of potential health concerns and recognizing subtle shifts in health metrics, timely interventions become possible. This not only enhances patient outcomes but also curtails healthcare expenses, driving the segment's growth. In 2023, North America's medical tricorder market was valued at USD 1.7 billion, with projections of a 5% CAGR over the analysis period.

North America's stringent regulations, like the Drug Supply Chain Security Act (DSCSA), are pivotal in promoting advanced diagnostic tools, including medical tricorders. Such regulations emphasize the need for meticulous tracking and monitoring of pharmaceuticals, thereby fostering the adoption of sophisticated devices for regulatory compliance. Moreover, North America's robust and technologically advanced healthcare infrastructure, coupled with its commitment to innovation, paves the way for the seamless integration of state-of-the-art solutions like medical tricorders.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of chronic diseases
  - 3.2.1.2 Technological advancements in sensor technologies
  - 3.2.1.3 Rising emphasis on preventive care
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High device cost coupled with data privacy concerns
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Porter's analysis
3.7 PESTEL analysis
3.8 Future market trends
3.9 GAP analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Sensors and biosensors
5.3 Imaging technology

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Monitoring
6.3 Diagnosis

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Brick & mortar
7.3 E-commerce

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals & clinics
8.3 Homecare
8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa